Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery Barbara A Konkle, MD, Thomas L Bauer, MD, Gowthami.

Slides:

Advertisements

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Advertisements

Autologous blood donation with recombinant human erythropoietin in anemic patients Hiroshi Kiyama, MD, Nagahisa Ohshima, MD, Takao Imazeki, MD, Takashi.

Heparin-coated catheters and heparin-induced thrombocytopenia

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Stephen R. Broderick, MD, MPHS

Coronary Artery Bypass Grafting in Immune Thrombocytopenic Purpura

Autologous blood donation with recombinant human erythropoietin in anemic patients Hiroshi Kiyama, MD, Nagahisa Ohshima, MD, Takao Imazeki, MD, Takashi.

Heparin-induced thrombocytopenia: twenty-nine years later

Late Results and Reintervention After Aortic Valvotomy for Critical Aortic Stenosis in Neonates and Infants John A Hawkins, MD, L.LuAnn Minich, MD, Lloyd.

Immunology and failure of valved allografts in children

Michael M. Mauney, MD, David C. Cassada, MD, Aditya K

Robert J Cerfolio, MD, Cyndi Bass, MSN, Charles R Katholi, PhD

Thomas F Floyd, MD, Michael McGarvey, MD, E

Pediatric tracheal surgery

Management of catheter-induced pulmonary artery perforation: a rare complication in cardiovascular operations Srikrishna Sirivella, MD, Isaac Gielchinsky,

CTSNet: a unique educational vehicle

Michael Frenken, MD, Arno Krian, MD The Annals of Thoracic Surgery

Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Nestor R

Prevalence of Heparin/Platelet Factor 4 Antibodies Before and After Cardiac Surgery Brendan M. Everett, MD, Robert Yeh, MD, Shi Yin Foo, MD, PhD, David.

Complete Aortic Valve Cusp Replacement in the Pediatric Population Using Tissue- Engineered Bovine Pericardium Domenico Mazzitelli, MD, Christian Nöbauer,

Aprotinin and Dipyridamole for the Safe Reduction of Postoperative Blood Loss Gideon Cohen, Joan Ivanov, Richard D Weisel, Vivek Rao, Molly K Mohabeer,

What is the marginal cost for marginal risk in cardiac surgery?

Coronary artery operation in patients after breast cancer therapy

Pain and quality of life after minimally invasive versus conventional cardiac surgery Thomas Walther, MD, Volkmar Falk, MD, Sebastian Metz, Anno Diegeler,

When is HIT Really HIT? The Annals of Thoracic Surgery

Oxidative Stress and Atrial Fibrillation After Cardiac Surgery: A Case-Control Study Basel Ramlawi, MD, MMSc, Hasan Otu, PhD, Shigetoshi Mieno, MD, Munir.

The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting Stephen R Hazelrigg, MD, Theresa M Boley,

Superior sulcus (Pancoast) tumor: experience with 105 patients

John Alfred Carr, MD, Joseph J. Amato, MD, Robert S.D. Higgins, MD

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Heparin-induced thrombosis without thrombocytopenia

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Heparin-induced thrombocytopenia and cardiac surgery

Heparin-coated catheters and heparin-induced thrombocytopenia

Seth D. Goldstein, MD, Stephen C. Yang, MD

Use of Amiodarone After Major Lung Resection

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Anne H Kuitunen, MD, Lasse J Heikkilä, MD, Markku T Salmenperä, MD

One-stage coronary and abdominal aortic operation with or without cardiopulmonary bypass: early and midterm follow-up Raimondo Ascione, MD, Gabriele.

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Pathology of the Radial and Internal Thoracic Arteries Used as Coronary Artery Bypass Grafts Eric Kaufer, BS, Stephen M Factor, MD, Rosemary Frame, MS,

Effect of blood transfusion on long-term survival after cardiac operation Milo C Engoren, MD, Robert H Habib, PhD, Anoar Zacharias, MD, Thomas A Schwann,

Traumatic tricuspid valve regurgitation and cerebral emboli

Stephen R. Broderick, MD, MPHS

Effect of cerebral embolization on regional autoregulation during cardiopulmonary bypass in dogs Hulya Sungurtekin, MD, Umar S Boston, MD, Thomas A Orszulak,

Cassandra Joffs, MD, Himali R. Gunasinghe, BS, Marlina M

Editorial Board, January 2010

Repair of an aneurysm of the pulmonary trunk in a 65-year-old patient

Platelet and Neutrophil Activation During Cardiac Surgical Procedures: Impact of Cardiopulmonary Bypass David S Morse, David Adams, Barbarajean Magnani

Vacuum-Assisted Closure for the Treatment of Complex Chest Wounds

Two Consecutive Open Heart Operations in a Small Child With Heparin-Induced Thrombocytopenia Type II Using Anticoagulation With Heparin and Tirofiban

Stephanie B. Clayton, PharmD, Jeffrey R. Acsell, CCP, Arthur J

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Olaf Reinhartz, MD, Anil M DeSilva, MD, Frank L Hanley, MD

Functional and Physiologic Results of Video-Assisted Thoracoscopic Diaphragm Plication in Adult Patients With Unilateral Diaphragm Paralysis Richard.

Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.

The American Board of Thoracic Surgery: Update

Neal S Goldstein, MD The Annals of Thoracic Surgery

Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A metaanalysis Michael A Borger, MD, Stephen E Fremes, MD, Richard.

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury Christine S Rinder, MD, Manuel Fontes, MD,

Preoperative immunoglobulin treatment in patients with Werlhof’s disease undergoing cardiac operation Stefan Christiansen, MD, Christof Schmid, MD, Klaus.

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Safety of low hematocrits during cardiopulmonary bypass

Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia Matthias Bauer, MD, Andreas Koster, MD, Miralem Pasic,

Stephen Greer, MD, Ashley D. Miller, FNP, Jeremiah S

Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation

On-pump versus off-pump coronary artery bypass grafting: impact on postoperative renal failure requiring renal replacement therapy Jan Bucerius, MD,

Presentation transcript:

Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery Barbara A Konkle, MD, Thomas L Bauer, MD, Gowthami Arepally, MD, Douglas B Cines, MD, Mortimer Poncz, MD, Stephen McNulty, Richard N Edie, MD, John D Mannion, MD The Annals of Thoracic Surgery Volume 71, Issue 6, Pages 1920-1924 (June 2001) DOI: 10.1016/S0003-4975(01)02534-6

Fig 1 Number of patients testing negative (Neg), intermediate (Int), or positive (Pos), by enzyme-linked immunosorbent assay for anti–heparin/PF4 antibodies preoperatively (Pre-Op) and postoperatively (Post-Op). The Annals of Thoracic Surgery 2001 71, 1920-1924DOI: (10.1016/S0003-4975(01)02534-6)

Fig 2 Mean platelet count of patients receiving either bovine or porcine heparin preoperatively (Pre-Op) and on days 1 to 5 postoperatively (Post-Op). The Annals of Thoracic Surgery 2001 71, 1920-1924DOI: (10.1016/S0003-4975(01)02534-6)